Inventor · disambiguated record
Soman Abraham
Also filed as: ABRAHAM SOMAN · ABRAHAM SOMAN N · ABRAHAM SOMAN NINAN
8 granted patents·3 pending applications·19 citations·filing 2004–2022
82Inventor score
Top patents by PatentIndex Score
11 records- 0185US10245319B2Lymph node-targeting nanoparticlesUNIV DUKE·Filed 2017·Granted Apr 2, 2019·2 cites·4 claims
- 0283US9730921B2Compositions and methods for the prevention and treatment of mast cell-induced vascular leakageUNIV DUKE·Filed 2013·Granted Aug 15, 2017·5 cites·12 claims
- 0383US8802076B2Compositions and methods for modulating an immune responseABRAHAM SOMAN·Filed 2011·Granted Aug 12, 2014·6 cites·5 claims
- 0478US9782475B2Method of treating food allergies by administering a nanoparticle comprising heparin and chitosan encapsulating IL-12UNIV DUKE·Filed 2014·Granted Oct 10, 2017·1 cites·5 claims
- 0571US10668059B2Compositions and methods for the prevention and treatment of mast cell-induced vascular leakageUNIV DUKE·Filed 2017·Granted Jun 2, 2020·1 cites·13 claims
- 0671US9301999B2Peptide, adjuvants, vaccines, and methods of useSTAATS HERMAN F·Filed 2010·Granted Apr 5, 2016·4 cites·10 claims
- 0758US12491237B2Vaccine compositions and methods for the treatment and prevention of urinary tract infectionsUNIV DUKE·Filed 2022·Granted Dec 9, 2025·0 cites·29 claims
- 0852US2011171195A1Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic ampUNIV DUKE·Filed 2008·Application pending·0 cites
- 0948US8076059B2Adjuvant capable of specifically activating the adaptive immune responsePIZZO SALVATORE V·Filed 2004·Granted Dec 13, 2011·0 cites·18 claims
- 1046US2014128399A1Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic ampUNIV DUKE·Filed 2013·Application pending·0 cites
- 1141US2015160240A1Host Biomarkers for Dengue Fever (DF) and Methods ThereofUNIV SINGAPORE·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Soman Abraham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →